Health Care & Life Sciences » Biotechnology | Retrophin Inc.

Retrophin Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
28,203.20
99,892.00
133,591.00
154,937.00
164,246
Cost of Goods Sold (COGS) incl. D&A
216.00
5,972.00
15,577.00
20,689.00
21,409.00
23,555
Gross Income
216.00
22,231.20
84,315.00
112,902.00
133,528.00
140,691
SG&A Expense
24,557.50
102,038.90
116,575.00
147,521.00
161,697.00
209,383
EBIT
-
79,807.70
-
34,619.00
28,169.00
68,692
Unusual Expense
10,099.90
23,786.10
40,446.00
21,940.00
30,113.00
28,390
Non Operating Income/Expense
370.60
2,351.80
188,771.00
264.00
1,107.00
474
Interest Expense
46.30
12,155.70
10,598.00
2,659.00
1,888.00
9,810
Pretax Income
34,549.10
113,397.60
105,467.00
57,582.00
58,363.00
101,867
Income Tax
75.80
2,459.70
11,770.00
9,679.00
1,368.00
811
Consolidated Net Income
34,624.90
110,937.90
117,237.00
47,903.00
59,731.00
102,678
Net Income
34,624.90
110,937.90
117,237.00
47,903.00
59,731.00
102,678
Net Income After Extraordinaries
34,624.90
110,937.90
117,237.00
47,903.00
59,731.00
102,678
Net Income Available to Common
34,624.90
110,937.90
117,237.00
47,903.00
59,731.00
102,678
EPS (Basic)
2.44
4.43
3.17
1.29
1.54
2.54
Basic Shares Outstanding
14,205.30
25,057.50
33,560.20
36,997.90
38,769.80
40,433.20
EPS (Diluted)
2.44
4.43
3.17
1.29
1.54
2.54
Diluted Shares Outstanding
14,205.30
25,057.50
37,581.40
38,288.00
38,769.80
40,433.20
EBITDA
24,557.50
74,406.70
18,868.00
18,484.00
10,365.00
50,024
Non-Operating Interest Income
-
-
-
1,900.00
700.00
5,499

About Retrophin

View Profile
Address
3721 Valley Centre Drive
San Diego California 92130
United States
Employees -
Website http://www.retrophin.com
Updated 07/08/2019
Retrophin, Inc. is a biopharmaceutical company, which engages in identifying, developing, and delivering therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.